Companies such as Pfizer and Merck, which have cooperative relations with Changtian Technology Intensive Care Center, have always been very optimistic about Changtian Technology''s cell totipotency therapy.


    They have repeatedly sent representatives to Changtian Technology, hoping to open cell totipotent therapy in the overseas comprehensive treatment center that cooperates with Changtian Technology.


    However, this matter was not promised by Changtian Technology.


    The most important reason is that the medical resources of the cell totipotent therapy are still insufficient.


    The content of this chapter is being updated...